General Information of Drug (ID: DMUE4K3)

Drug Name
4,5,6,7-tetrabromo-1H-benzimidazole Drug Info
Synonyms
4,5,6,7-tetrabromobenzimidazole; TBBz; 577779-57-8; 4,5,6,7-Tetrabromo-Benzimidazole; 4,5,6,7-tetrabromo-1H-benzo[d]imidazole; CHEMBL373937; 2oxy; AC1NP4E4; SCHEMBL406945; CTK5I6050; DTXSID80408803; MolPort-003-850-464; LOEIRDBRYBHAJB-UHFFFAOYSA-N; HMS3260K22; ZINC2528524; Tox21_500140; BDBM50156669; TBBz, > MFCD04116202; 4,5,6,7-Tetrabromo-1Hbenzimidazole; LP00140; CCG-221444; NCGC00260825-01; NCGC00165910-02; NCGC00165910-01; RT-009016; FT-0674936
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
5149739
CAS Number
CAS 577779-57-8
TTD Drug ID
DMUE4K3

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Casein kinase II alpha (CSNK2A1) TTER6YH CSK21_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Casein kinase II alpha (CSNK2A1) DTT CSNK2A1 5.162 6.628 6.981 6.144
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Casein kinase II alpha (CSNK2A1) DTT CSNK2A1 6.82E-04 0.29 2.43
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2. Bioorg Med Chem. 2009 Feb 15;17(4):1573-8.